About us

FASTinov is an AI-enabled precision diagnostics company in the field of rapid Antimicrobial Susceptibility Testing (AST) set to revolutionize clinicians' access to timely information in order to optimally treat life-threatening bacterial infections and avoid antimicrobial resistance spreading, morbidity and mortality in sepsis and beyond.

FASTinov's precision diagnostics reduce the standard time-to-response of AST from 48 h to 2 h to enable unprecedented optimal clinical use of precious antibiotics in the battle against the hidden pandemic of antimicrobial resistance.

It is the fastest antibiogram in the world.

President and CEO
Nuno Afonso

Nuno currently leads FASTinov. He is also a founding partner at HinnovaCare Business Advisory. In the past Nuno worked in VC with Portugal Ventures, in Pharmaceuticals with J&J / Janssen, and founded TechnoZeb/TechnoPhage. His academic background includes a Post-Doc Research (IMM/IGC Portugal), a PhD from the Université Pierre et Marie Curie (Paris, France 2005) and an MBA from The Lisbon MBA (2012).

Founder & CSO
Cidália Pina Vaz

Cidália is a founder of FASTinov. With a long experience in academia as an Associate Professor at the Faculty of Medicine, University of Porto, as well as a Clinical Pathology consultant at the São João hospital in Porto. She was the Portugal national representative and steering committee member of EUCAST for AST. With 300+ publications, she has an MD from the U. Porto (1988) and a PhD in Medicine (2000).

UPTEC Corporate campus

  • Science and Technology Park, R. Alfredo Allen, 4200-135 Porto Portugal

Get in touch